GET DAILY SIGNALSCorteva (CTVA) Q3 2026 Earnings: Pro Forma Sales Drop -9% as Brazil Weighs on Results
Key Takeaways
- Corteva reported third quarter 2026 pro forma net sales of $1.59 billion, down 9% year over year and below the roughly $1.77 billion consensus estimate.
- Adjusted pro forma operating earnings per share (EPS) came in at $0.06, down from $0.14 in the prior-year quarter.
- Latin America organic sales plunged 31%, driven by deteriorating market conditions, elevated channel inventories, and farmers' financing constraints in Brazil.
- North America, EMEA (Europe, Middle East, and Africa), and Asia Pacific delivered organic growth, partially offsetting the Latin America decline.
- The company lowered its full-year 2026 outlook and announced a restructuring to optimize its crop protection manufacturing network.
Why These Results Matter
Corteva, a global agricultural products company focused on crop protection, is reporting its third quarter 2026 results just weeks after a major structural change. On October 1, 2026, the company completed the separation of its seed business into a separate entity, leaving CTVA as a pure-play crop protection operation. As a result, results are presented on a pro forma continuing-operations basis. This quarter therefore offers investors their first clear read on the standalone crop protection business. The results also matter because they capture deteriorating conditions in Brazil, a key agricultural market, and reveal how management is responding through cost actions and guidance changes. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Numbers
For the third quarter of 2026, Corteva reported pro forma net sales of $1.59 billion, a 9% decline from $1.74 billion a year earlier and below the roughly $1.77 billion consensus estimate. Adjusted pro forma operating EBITDA (earnings before interest, taxes, depreciation, and amortization) fell 17% to $222 million, while adjusted pro forma operating EPS dropped 57% to $0.06, compared with $0.14 in the prior-year period.
Regional performance was sharply mixed. Latin America organic sales tumbled 31%, reflecting weaker Brazilian market conditions, high channel inventories, and financing constraints among farmers. By contrast, North America organic sales rose 7%, EMEA increased 14%, and Asia Pacific advanced 5%. On a reported basis, net sales in Latin America fell 28% to $570 million.
Corteva also updated its full-year 2026 guidance. The company now expects adjusted pro forma operating EBITDA of $1.10 billion to $1.125 billion and adjusted pro forma operating EPS of $0.76 to $0.80, reflecting the post-separation crop protection business and softer conditions in Brazil.
Market Reaction and Investor Sentiment
Investor sentiment around CTVA has been pressured by both the recent separation and persistent weakness in Brazil. The stock has declined sharply over the past year, reflecting the structural change and softer crop protection demand. The third quarter revenue miss and the reduction in full-year guidance underscore the challenges facing the newly focused business, even as growth in North America, EMEA, and Asia Pacific provided some balance. Management characterized the deterioration in Brazil as exceeding its earlier expectations, while pointing to productivity gains and new product momentum as partial offsets. The combination of a top-line shortfall and lowered outlook is likely to keep near-term sentiment cautious.
Forward Outlook and Key Factors to Monitor
Looking ahead, investors will want to track whether conditions in Brazil begin to stabilize. Management cited normalization of channel inventories, weather conditions, and elevated financing costs as key variables shaping the second half of the year. Any sign that farmer purchasing activity improves in Latin America would be an important signal for the crop protection business.
At the same time, Corteva is undertaking an operational transformation program. The company announced a restructuring to optimize its crop protection network of manufacturing and external partners, expecting to record roughly $130 million to $140 million in net pre-tax restructuring charges during 2026, with substantial completion by 2028. The pace and payoff of these cost actions will be worth watching.
Finally, investors should monitor the company's new product pipeline and pricing trends, particularly competition from generic products in Brazil and pressure on acetochlor-based herbicides in the United States. Management reported 20% growth in new product volume, which could help support future revenue as the company navigates a challenging operating environment.
Using AI Tools in My Analysis
When reviewing results like these, I often turn to Tickeron’s AI Screener as part of my routine to filter for comparable names in the agricultural space and review technical signals alongside fundamentals. It helps me quickly surface ideas and context without replacing my own judgment on the numbers.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CTVA's RSI Oscillator climbs out of oversold territory
The RSI Oscillator for CTVA moved out of oversold territory on October 29, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In 22 of the 29 cases the stock moved higher. This puts the odds of a move higher at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 53 cases where CTVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on CTVA as a result. In 48 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for CTVA just turned positive on November 10, 2026. Looking at past instances where CTVA's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTVA advanced for three days, in 216 of 343 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
CTVA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
CTVA moved below its 50-day moving average on October 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CTVA crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
The Aroon Indicator for CTVA entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.316) is normal, around the industry mean (-0.492). P/E Ratio (7.778) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.011) is also within normal values, averaging (0.867). Dividend Yield (0.026) settles around the average of (0.126) among similar stocks. CTVA's P/S Ratio (3.069) is slightly higher than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. CTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a holding company, which engages in the provision of agricultural products.
Industry ChemicalsAgricultural
Advertisement